|
| Press Releases |
|
 |
|
| Wednesday, June 15, 2022 |
|
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
| Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
| Monday, March 14, 2022 |
|
|
雅各臣獲主席增持股份至超過六成 |
| 從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「公司」；連同其附屬公司統稱「集團」；股份代號：2633 ) 獲集團主席岑廣業先生於二零二一年十二月十五日至二零二二年三月十四日期間 more info >> |
|
|
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60% |
| Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the "Company"; together with its subsidiaries, the "Group"; Stock Code: 2633), a leading company engaged in the research more info >> |
|
| Friday, November 26, 2021 |
|
|
雅各臣公布二零二二财年中期业绩 |
| 从事基础药物、专科药物及品牌医疗保健产品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633 )今天公布公司及其附属公司（统称「集团」）截至二零二一年九月三十日止六个月（「报告期」）的中期业绩。 more info >> |
|
|
雅各臣公佈二零二二財年中期業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633 )今天公佈公司及其附屬公司（統稱「集團」）截至二零二一年九月三十日止六個月（「報告期」）的中期業績。 more info >> |
|
|
Jacobson Pharma Announces FY2022 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines more info >> |
|
| Tuesday, June 29, 2021 |
|
|
雅各臣公布二零二一财年全年业绩 |
| 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633 )今天公布公司及其附属公司（统称「集团」）于截至二零二一年三月三十一日止年度（「二零二一财年」或「报告期」）的全年业绩。 more info >> |
|
|
雅各臣公佈二零二一財年全年業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633 )今天公佈公司及其附屬公司（統稱「集團」）於截至二零二一年三月三十一日止年度（「二零二一財年」或「報告期」）的全年業績。 more info >> |
|
|
Jacobson Pharma Announces FY2021 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products more info >> |
|
| Friday, February 5, 2021 |
|
|
健倍苗苗（保健）有限公司於香港聯交所主板掛牌上市 |
| 健倍苗苗（保健）有限公司 （「健倍苗苗」 或「公司」，連同其附屬公司統稱「集團」），一家總部設於香港的領先品牌醫療保健品推廣及分銷公司，業務遍及大中華、東南亞及其他選定國家，今天於香港聯合交易所有限公司（「香港聯交所」）主板正式掛牌買賣，股份代號為2161。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Breaking ground: Power Women lay the foundation for the real estate industry's future
Mar 4, 2025 11:20 HKT/SGT
|
|
|
富士通、東海地域大手小売業のバローホールディングス様にてデータ連携基盤「Fujitsu Supply Chain Data Service」が運用開始
Mar 4, 2025 10:30: JST
|
|
|
GA-ASI Welcomes USAF Designation for New CCA: YFQ-42A
Mar 4, 2025 10:00 HKT/SGT
|
|
|
佐藤製薬とエーザイ、経口抗真菌剤「ネイリン カプセル100mg」の日本におけるコ・プロモーションについて発表
Mar 4, 2025 10:00: JST
|
|
|
MBZUAI Unveils First-of-its-Kind Undergraduate Program in Artificial Intelligence Designed to Empower Future AI Leaders
Mar 4, 2025 09:00 HKT/SGT
|
|
|
Global Advanced Metals連續15年符合礦產盡職調查審計標準
Mar 3, 2025 23:50 HKT/SGT
|
|
|
Global Advanced Metals连续15年符合矿产尽职调查审计标准
Mar 3, 2025 23:44 HKT/SGT
|
|
|
Global Advanced Metals Declared Conformant to Minerals Due Diligence Audit Standard for 15 Consecutive Years
Mar 3, 2025 23:38 HKT/SGT
|
|
|
來源修正：通用原子公司收購北點防務公司
Mar 3, 2025 23:28 HKT/SGT
|
|
|
CORRECTION FROM SOURCE: General Atomics Acquires North Point Defense
Mar 3, 2025 23:23 HKT/SGT
|
|
|
LaFleur Minerals to Restart Gold Milling at Beacon Gold Mill in Val-d'Or, Quebec
Mar 3, 2025 22:29 HKT/SGT
|
|
|
GMG's Graphene Aluminium-Ion Battery: Collaboration with World Leading USA Battery Innovation Centre and Next Steps Toward Commercialisation
Mar 3, 2025 21:29 HKT/SGT
|
|
|
奇瑞汽車擬來港上市 或成近年汽車行業最大IPO
Mar 3, 2025 21:17 HKT/SGT
|
|
|
蜜雪集團創香港新股IPO紀錄 公開發售認購火爆
Mar 3, 2025 21:16 HKT/SGT
|
|
|
蜜雪集團在港上市 開啟打造全球化百年品牌璀璨新途
Mar 3, 2025 21:15 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
